Prometheus Biosciences Inc (RXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38,347 | 46,383 | 57,567 | 53,556 | 43,044 |
| Marketable Securities | 75,588 | 85,420 | 81,413 | 55,098 | 44,909 |
| TOTAL | $118,261 | $135,994 | $143,080 | $111,219 | $89,484 |
| Non-Current Assets | |||||
| PPE Net | 19,373 | 18,764 | 7,588 | 7,568 | 6,551 |
| Investments And Advances | 37,257 | 40,346 | 24,127 | 57,735 | 19,612 |
| Other Non-Current Assets | 410 | 410 | 540 | 523 | 596 |
| TOTAL | $57,040 | $59,520 | $32,254 | $65,826 | $26,759 |
| Total Assets | $175,301 | $195,514 | $175,334 | $177,045 | $116,243 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 6,675 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 8,807 | 14,025 | 3,246 | 1,772 | 1,845 |
| Accrued Expenses | 11,187 | 3,844 | 6,951 | 6,863 | 4,224 |
| TOTAL | $29,439 | $24,544 | $14,681 | $9,978 | $9,743 |
| Non-Current Liabilities | |||||
| Long Term Debt | 20,363 | 22,821 | 25,746 | 19,196 | 16,797 |
| Other Non-Current Liabilities | 12,910 | 12,164 | 2,625 | 2,454 | 2,582 |
| TOTAL | $33,390 | $34,985 | $28,581 | $21,906 | $19,679 |
| Total Liabilities | $62,829 | $59,529 | $43,263 | $31,884 | $29,422 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,646 | 32,339 | 29,620 | 29,599 | 25,262 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -173,512 | -148,021 | -106,810 | -92,189 | -79,069 |
| Other shareholders' equity | 15 | -249 | -12 | -75 | -25 |
| TOTAL | $112,472 | $135,985 | $132,071 | $145,161 | $86,822 |
| Total Liabilities And Equity | $175,301 | $195,514 | $175,334 | $177,045 | $116,243 |